About | Free Trial

Last Update

2016-01-21T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Mark Gelder?

Dr. Mark Gelder S. MD

Vice President Clinical Development

Inovio Biomedical Corporation

HQ Phone: (858) 597-6006

Email: m***@***.com

Inovio Biomedical Corporation

10480 Wateridge Circle

San Diego, California 92121

United States

Company Description

Inovio Biomedical Corporation (Inovio) is a San Diego-based biomedical company focused on the development of vaccines to prevent or treat cancers and chronic infectious diseases. Inovio develops deoxyribonucleic acid (DNA) delivery solutions based on elec... more

Find other employees at this company (167)

Background Information

Employment History

Senior Vice President and Chief Medical Officer
Heron Therapeutics Inc

Senior Vice President and Chief Marketing Officer
A.P. Pharma Inc

Vice President of Global Medical Affairs of Oncology
Bayer AG

Vice President, Global Head Medical Affairs and PV, Medical Diagnostics and NPD
GE Healthcare Ltd

Senior Director, Oncology
Wyeth

Education

B.S. degree
biochemistry
Colgate University

M.D.

M.D. degree

University of Virginia's School of Medicine

Web References (83 Total References)


Mark Stephen Gelder , M.D., an ...

ir.inovio.com [cached]

Mark Stephen Gelder , M.D., an experienced gynecologic oncologist, was appointed Vice President, Clinical Development to lead Inovio's clinical development of its immunotherapies against HPV-caused cervical cancer and dysplasia, including our planned phase III study for VGX-3100. Prior to joining Inovio he was Chief Medical Officer at


Heron Therapeutics . A Specialty Pharmaceutical Company • Investor Relations • News Release

phx.corporate-ir.net [cached]

, the Company announced the appointment of Mark S. Gelder, M.D. as Senior Vice President and Chief Medical Officer.


Heron Therapeutics . A Biotechnology Company • Investor Relations • 2012 News Releases

phx.corporate-ir.net [cached]

A.P. Pharma Names Mark S. Gelder, M.D. as Senior Vice President and Chief Medical Officer

...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Dec. 13, 2012-- A.P. Pharma, Inc. (OTCBB: APPA.OB), a specialty pharmaceutical company, today announced the appointment of Mark S. Gelder, M.D. as senior vice president and chief medical officer. The addition of Dr. Gelder to A.P. Pharma’s executive team represents the Company’s continued efforts related to pre-commercialization activities for APF530, the Company’s lead product candidate for the prevention of chemotherapy-induced nausea and vomiting, if app...Â


Heron Therapeutics . A Biotechnology Company • Investor Relations • News Release

phx.corporate-ir.net [cached]

, the Company announced the appointment of Mark S. Gelder, M.D. as Senior Vice President and Chief Medical Officer.


Clinical Research News and Views on the Global Clinical Trials Industry | CenterWatch News Online

www.centerwatch.com [cached]

Inovio Pharmaceuticals appoints Mark Gelder vice president, clinical development

Similar Profiles

Other People with this Name

Other people with the name Gelder

Alan Van Gelder
Greene Broillet & Wheeler L.L.P

Bob Van Gelder
Siouxland Energy

Matt Gelder
Clinic

Carin Van Gelder
EMS Medical Director NHSHP

Eric Van Gelder
CHC Bold Pac

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory